University. I write to present the case of posterior scleritis simulating intraocular tumor. A formal review and approval were waived by Institutional Review Board in Hokkaido University. The principles outlined in the Declaration of Helsinki were followed. Written informed consent on publishing the clinical and laboratory data was obtained from this patient. A 59-year-old woman complained of blurred vision and eyelid swelling without obvious ocular pain in her right eye. When she visited a nearby clinic several months before, her bestcorrected visual acuity (BCVA) was 0.4 OD and 1.2 OS. Slitlamp examination revealed senile cataract OD. She underwent cataract surgery OD. Although her BCVA improved to 1.0 after the surgery, she noticed right upper lid swelling with mild irritation. Since magnetic resonance imaging (MRI) displayed markedly thickened scleral lesions, she was referred to Department of Ophthalmology, Hokkaido University Hospital for further examinations and management. Her BCVA was 1.0 OD within normal range of intraocular pressure at the initial presentation. Slit-lamp examination revealed subconjunctival elevated lesions with injection in the superonasal side OD ( Figure 1A ). Fundus examination ( Figure 1B) showed choroidal folds in the supero-temporal side. B-mode ultrasonography displayed marked thickening of the posterior sclera which showed hyperreflective in the temporal and nasal sides, measuring 5-mm thickness in maximum ( Figure 1C ). OCT displayed an irregular retinal pigment epithelial layer in the temporal side of the macula ( Figure 1D ). MRI displayed marked posterior scleral thickening enhanced by gadolinium ( Figure 1E ). She did not have any other past medical history except for well-controlled hypertension. Family history was unremarkable. Blood test showed a positive for Hepatitis B virus antigen, and serum IgG and IgG4 levels were within the normal range; 1505 mg/dL and 108 mg/dL, respectively. The other serological findings such as C-reactive protein, rheumatoid factor, antinuclear antibody, anti-thyroglobulin antibody, and anti-thyroid peroxidase antibody were all negative. Based on clinical findings, nodular-type posterior scleritis or IgG4-related ophthalmic disease (IgG4-ROD) was initially considered; however, it was difficult to differentiate malignancies from benign lymphoproliferative disorders. Therefore, local resection of the episcleral lesions was scheduled to make a histopathological diagnosis. Whitish elevated lesions were exposed following conjunctival incision in the supero-nasal side, in which a part of the lesions was resected. Microscopic examination showed inflammatory cell infiltration located in the episclera (Figure 2A ), made up of lymphocytes and plasma cells ( Figure 2B1) , with fibrous tissues ( Figure 2B2 ). Immunohistochemical examination demonstrated that CD3-positive T-cells, CD20/5-positive B-cells, and CD138-positive plasma cells infiltrated into the tissue. Immunoglobulin light chain restriction by λ and κ deviation was not identified. Some plasma cells were positive for IgG, whereas the population of cells being positive for IgG4 was less than 40% ( Figure 2C ). There were no wellconfigured lymphoid follicles, granulomatous inflammation or necrosis. Based on the findings, clinical diagnosis in this case was nodular posterior scleritis, and pathological diagnosis was reactive lymphoid hyperplasia. Systemic administration of prednisolone at the dose of 20 mg was given, which was tapered gradually, since scleral thickening was decreased. Slit lamp examination showed the elevated lesions with conjunctival injection are resolved ( Figure 1F) . B-mode image showed reduced scleral thickening ( Figure 1H ).
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Nodular posterior scleritis simulating tumor
Taken together, it was mandatory to make a histological diagnosis in this case.
In our case, microscopic examination revealed lymphoplasmacytic infiltration as well as fibrosis in the episclera that might be similar with the previous reported case [9] . On the contrary, according to the diagnostic criteria of IgG4-ROD [10] , our present case did not satisfy the histological criteria.
Moreover, this case showed no elevation of serum IgG4 levels.
Therefore, the current case could not be diagnosed with IgG4-ROD. Riono et al [11] proposed histological classification of posterior scleritis, which is divided into four morphologic groups: zonal necrotizing granulomatous inflammation (Group 1), non-zonal diffuse granulomatous inflammation (Group 2), necrotizing inflammation with microabscesses (Group 3), and sarcoid granulomatous inflammation (Group 4).
Our case might be partly consistent with Group 2; however, our case is unique because of episcleral involvement, but not total scleral wall involvement, made up of chronic inflammatory cells, without lymphoid follicle, granulomatous inflammation nor microfoci of necrosis, the latter of which could be found in Group 2 posterior scleritis [11] .
A part of patients with posterior scleritis may be associated with systemic diseases including rheumatoid arthritis, systemic vasculitis, and granulomatosis with polyangiitis. Since she did not have medical history of collagen disease or any specific blood findings before, the cause of inflammation was considered idiopathic in this case. It has been demonstrated that scleritis associated with systemic autoimmune diseases and idiopathic scleritis had different pathological features [11] .
Scleritis with systemic autoimmune diseases was involved with an immune complex-mediated process, whereas idiopathic scleritis is less likely to have this process. Cases with zonal necrotizing granulomatous scleritis were primary associated with systemic autoimmune diseases, while those with nonzonal diffuse scleral inflammation showed no evidence of associated systemic diseases [11] . This observation is consistent with our case because our patient had a non-zonal diffuse nonspecific inflammation without any systemic disorders.
In conclusions, when ophthalmologists noticed markedly thickened sclera, intraocular tumors such as malignant lymphoma and melanoma as well as IgG4-ROD should be included as differential diagnoses. This nodular posterior scleritis showing markedly thickened sclera histologically revealed non-zonal diffuse inflammation.
